Cagrilintide
A long-acting synthetic analogue of amylin, a peptide hormone released with insulin, injected weekly. Investigational: Novo Nordisk is developing it mostly in combination with semaglutide, as CagriSema, and it is not approved anywhere; sold online as a research chemical.
Longevity0 public stacks
Substance
Cagrilintide
- Route
- Injection Injected
- Measured in
- mg milligrams
- Comes as
- vial
Also
Public stacks with it 0
No public stack has it yet.